Sudhin Biopharma Co. was founded with the mission to revolutionize the biomanufacturing industry by developing efficient continuous biological manufacturing processes. The company focuses on producing therapeutic biologicals and viral vaccines using innovative technologies such as perfusion bioreactors and single-use biosettlers. Their market focus includes the biopharmaceutical sector, particularly in the areas of cell therapy applications and the production of antibodies and AAV vectors.
Notable affiliated people and investors include industry experts and venture capital firms specializing in biotechnology. Sudhin Biopharma has achieved significant milestones, including the development of proprietary technologies for cell culture clarification and selective cell retention. These innovations have made a substantial impact on improving the efficiency and scalability of biomanufacturing processes, positioning Sudhin Biopharma as a key player in the biotechnology industry.
